Indomethacin
USP/1341001 - United States Pharmacopeia (USP) Reference Standard
Synonym: 1-
CAS Number: 53-86-1
Empirical Formula (Hill Notation): C19H16ClNO4
Molecular Weight: 357.79
MDL Number: MFCD00057095
Linear Formula: C19H16ClNO4
Product Type: Chemical
| API family | indomethacin |
| application(s) | pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C19H16ClNO4/c1-11-15(1 |
| InChI key | CGIGDMFJXJATDK-UHFFFAOYSA |
| manufacturer/tradename | USP |
| SMILES string | COc1ccc2n(c(C)c(CC(O)=O)c |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Indomethacin USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as: • Indomethacin Capsules • Indomethacin Extended-Release Capsules • Indomethacin for Injection • Indomethacin Oral Suspension • Indomethacin Sodium • Indomethacin Suppositories |
| Biochem/physiol Actions: | Cyclooxygenase (COX) inhibitor that is relatively selective for COX-1. |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia   . |
| Other Notes: | Sales restrictions may apply. |
| Symbol |  GHS06 |
| Signal word | Danger |
| Hazard statements | H300 |
| Precautionary statements | P301 + P330 + P331 + P310 |
| RIDADR | UN 2811 6.1 / PGI |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |